MG MED Inc.

MG MED Inc.
Stock Exchange Korea Exchange
EPS
KRW269.33
Market Cap
KRW180.76 B
Shares Outstanding
18.89 M
Public Float
14.58 M

Profile

Address
Unit 1003, Elysia Building
Seoul SL 08511
Korea, Republic Of
Employees -
Website http://www.cancerrop.com
Updated 09/14/2018
Cancer Rop Co., Ltd. engages in the development of molecular diagnostic products. It operates through Molecular Diagnostics and Bio-Reagents Business divisions. The molecular diagnostic business division provides deoxyribonucleic acid (DNA) chips and polymerase chain reaction(PCR) kits.

Financials

View All

Jang-Woo Lee
Chief Executive Officer & Director
Yeon-Mok Oh
Non-Executive Director